The Asia Pacific cardiac monitoring market size is expected to register a significant CAGR during the forecast period, 2021–2028. Growth of the market is attributed to increased demand for home-based point-of-care and remote monitoring cardiac systems.

Cardiac monitoring devices are used to monitor and diagnose a variety of heart and circulatory system irregularities and diseases. Heart monitoring (CM) devices are used to keep track of a patient's cardiac activity in real time. Heart failure, atrial fibrillation, atrial flutter, signs of recent heart attack, coronary ischemia, lack of oxygen delivery to cardiac muscles, medication side effects, and some genetic defects are treated with CM devices. Continuous cardiac monitoring is required to check the patient's health if they have CVD. Cardiovascular diseases (CVD) are the major cause of mortality in Asia Pacific. Obesity, diabetes, lifestyle, and eating habits are all variables that contribute to cardiovascular disease. Due to rising incidences of cardiac diseases and the need to limit mortality rates by early detection and treatment of CVD with the aid of cardiac monitoring equipment, the rate of diagnosis for cardiovascular diseases is increasing over time.
The COVID-19 pandemic is expected to provide a significant boost to the cardiac monitoring devices. More than 200 economies have been affected by the virus, which has infected roughly 14 million individuals worldwide. It targets the body's respiratory system, causing changes in heart activity, therefore it's crucial to keep track of patients' vital signs and cardiac activity.
Market Trends, Drivers, Restraints, and Opportunities
- Rising prevalence of cardiovascular disease is expected to fuel the market during the forecast period.
- Favorable reimbursement policies are key factor propelling the market.
- High cost of diagnosis and treatment are projected to hamper the market growth.
- Rising demand for a better healthcare system is estimated to create lucrative opportunities for the market players.
Scope of the Report
The report on the Asia Pacific cardiac monitoring market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Asia Pacific Cardiac Monitoring Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2021
|
Historic Data
|
2019–2020
|
Forecast Period
|
2021–2028
|
Segmentation
|
Types (ECG Monitor, Event Recorder, Implantable Cardiac Loop Recorder, Pacemaker, and Others), Applications (Hospitals and Clinics, Home Care Settings, and Ambulatory Surgical Centers)
|
Regional Scope
|
China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Abbott Laboratories; Biotronik; Boston Scientific Corporation; GE Healthcare; Hill-Rom Holdings, Inc.
|
Market Segment Insights:
The ECG monitor segment is projected to hold a major market share
On the basis of types, the Asia Pacific cardiac monitoring market is segregated into ECG monitor, event recorder, implantable cardiac loop recorder, pacemaker, and others. The ECG monitor segment is expected to represent a key share of the market during the forecast period. The technique of creating an electrocardiogram is known as electrocardiography. The popularity of ECG monitors is expected to rise due to the introduction of commercially advanced devices with Bluetooth sensor technology and mobile app technology. Increasing incidence of the condition, as well as technological and product advances in the creation of ECG equipment, are expected to drive the market.

The hospital and clinical segment is anticipated to expand during the forecast period
In terms of applications, the Asia Pacific cardiac monitoring market is segmented into hospitals and clinics, home care settings, and ambulatory surgical centers. The hospitals segment is expected to represent a key share of the market during the forecast period. The hospitals segment holds a major market share. Factors such as the rising incidence of CVD, increasing number of patient visits to hospitals for diagnosis, rising number of cardiac implant operations, and availability of payment for these treatments drives the market.
China is projected to hold a major market share
In terms of geography, the Asia Pacific cardiac monitoring market is classified as China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific. China is anticipated to dominate the market during forecast period. Factors such as rising prevalence of CVD, increasing healthcare expenditure, rising disposable income, growing healthcare awareness, and availability of technologically advanced gadgets in the region boost the market.
Segments
Segments Covered in the Report
The Asia Pacific cardiac monitoring market is segmented on the basis of
Types
- ECG Monitor
- Event Recorder
- Implantable Cardiac Loop Recorder
- Pacemaker
- Others
End-users
- Hospitals and Clinics
- Home Care Settings
- Ambulatory Surgical Centers
Regions
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Key Players
- Abbott Laboratories
- Biotronik
- Boston Scientific Corporation
- GE Healthcare
- Hill-Rom Holdings, Inc.
Competitive Landscape
The major players in the Asia Pacific cardiac monitoring market include Abbott Laboratories, Biotronik, Boston Scientific Corporation, GE Healthcare, Hill-Rom Holdings, Inc.
Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
